ICMR and IIL Collaborate for Zika Virus Vaccine Development
Friday, 13 September 2024, 11:20
Overview of the Collaboration
ICMR (Indian Council of Medical Research) has partnered with IIL (Indian Immunologicals Limited) to develop a jab targeting the Zika virus. This collaboration aims to fortify public health measures against the virus.
Vaccine Development and Trials
- Phase I clinical trials are expected to begin shortly.
- This partnership focuses on innovative approaches to combat the Zika virus.
Importance of the Zika Virus Vaccine
The development of a Zika virus vaccine is critical as it aims to prevent severe health impacts from outbreaks.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.